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ABSTRACT

Multifunctional "smart" nanostructures are disclosed that
include fluorescein isothiocyanate (FITC)-encapsulated Si0 2
core-shell particles with a nanoscale ZnO finishing layer,
wherein an outer ZnO layer is formed on the Si0 2 - FITC core.
These -200 nm sized particles showed promise toward cell
imaging and cellular uptake studies using the bacterium
Escherichia coli and lurkat cancer cells, respectively. The
FITC encapsulated ZnO particles demonstrated excellent
selectivity in preferentially killing lurkat cancer cells with
minimal toxicity to normal primary immune cells (18% and
75% viability remaining, respectively, after exposure to 60
flglmL) and inhibited the growth of both gram-positive and
gram-negative bacteria at concentrations ~250-500 flg/mL
(for Staphylococcus aureus and Escherichia coli, respectively). These results indicate that the FITC encapsulated
multifunctional particles with nanoscale ZnO surface layer
can be used as smart nanostructures for particle tracking, cell
imaging, antibacterial treatments and cancer therapy.
9 Claims, 8 Drawing Sheets
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FLUORESCENT PARTICLES COMPRISING
NANOSCALE ZNO LAYER AND EXHIBITING
CELL-SPECIFIC TOXICITY

Escherichia coli (E. coli) and Staphylococcus aureus (s.
aureus) bacteria were completely killed by ZnO nanoparticles at concentrations ~3.4 mM and ~1.0 mM, respectively, with minimal effects on primary hnman T cells. More
recent experiments have shown that these nanoparticles have
superior ability to kill both lurkat and Hut-78 cancer cells at
micromolar concentrations at which normal cells displayed
no measurable cell death. Such an order of magnitude difference in toxicity to cancer cells relative to normal host T-cells
makes ZnO nanoparticles a potential candidate for cancer
therapy. Based on these interesting results, we have developed a core-shell structure with fluorescent FITC encapsulated in Si0 2 as the core and nanoscale ZnO as a surface layer,
hereafter referred as FITC-ZnO. These FITC-ZnO particles
were synthesized using a novel one-pot methodology involving successive hydrolysis and condensation of FITC-linked
silicate and zinc salt. The synergistic effects of ZnO and Si0 2
nanostructures on the optical properties of the fluorophores
and the toxic nature of the resulting nanostructures are
explored in detail. Moreover, although reactive oxygen species generated at the surface of excited nanomaterials are
generally thought to be responsible for observed biocidal
effects, the detailed mechanism of toxicity and their selective
nature to different biological systems still remains poorly
understood. Adding fluorescence functionality to the ZnO
nanostructures will aid future detailed in vitro and in vivo
studies necessary to understand the fundamental interaction!
uptake mechanism as well as improve our ability to evaluate
and efficiently utilize the therapeutic potential of ZnO nanoparticles. The present work focuses on the preparation and
characterization of fluorescent FITC-ZnO particles with an
untouched outer ZnO nanolayer and their ability to selectively kill certain types of cancer cells and bacteria. However,
no attempt is made in this work to address the mechanism of
cell-particle interactions and toxicity. These will be the subject matter of future publications.
Semiconducting ZnO has good chemical stability, wide
direct band-gap (Eg=3.37 eV) and large excitation binding
energy (60 meV), and has been studied for nnmerous applications including nanodevices, light-emitting diodes, sensors, luminescence, and photovoltaics. Thus the ZnO surface
layer of these novel core-shell FITC-ZnO nanostructures has
the added benefit of providing a robust platform for many
future applications. For example, Dorfman et al. (A. Dorfman, N. Kumar, 1. Hahm, Langmuir, 22, 4890 (2006); and A.
Dorfman, N. Kumar, 1. Hahm, Adv. Materials, 18, 2685
(2006)) developed nanoscale ZnO platforms for use as attractive substrates in fluorescence bioassays using FITC labels.
They found that ZnO nanorod substrates could significantly
enhance the fluorescence detection capability of proteins and
nucleic acids without any need for amplification of detection
signal. Moreover, ZnO nanocrystalslquantum dots might produce UV and visible fluorescence. Thus, addition of a stable
surface layer of ZnO on the fluorescent FITC-Si0 2 cores will
provide the core-shell particles with two different fluorescence sources. Changes in the ZnO fluorescence when biological species are attached to the outer surface could provide
opportunities for bio-sensing and the internal FITC fluorescence could serve as a reference standard to quantify relative
change in intensity and the surface attached species. To the
best of our knowledge, preparation and characterization of
fluorescent dye encapsulated particles with an active ZnO
finishing layer and their preferential cancer killing and bacterial inhibiting ability have not yet been reported.

This application claims priority of Provisional Application
No. 601974,461, filed Sep. 22, 2007, and entitled "Fluorescent Dye Encapsulated ZnO Particles with Cell-Specific Toxicity for Cancer Treatment and Bio-medical Applications,"
the entire disclosure of which is hereby incorporated herein
by this reference.
This research was supported in part by NSF-Idaho-EPSCoR Program (EPS-0447689), DoE-EPSCoR grant (DEFG02-04ER46142), NSF -CAREER award (DMR -0449639),
NSF-MRI grants (MRI-052131, MRI-0619793 and MRI0722699), and NIH awards (lRI5AI06277-01Al, lR43
AR052955-0l and P20RROI6454).
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BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to a new composition of
matter, a zinc oxide (ZnO) encapsulated fluorescent dye
nanoparticle in about the 200 nm range, with the ZnO outer
layer being about 10 nm. More specifically, this invention
relates to use of the new nanoparticle material as a fluorescence probe, antibacterial agent, or cancer treatment. Also,
this invention relates to ways to make the new material.
2. Background Art
The ongoing worldwide nanotechnology revolution is predicted to impact several areas of biomedical research and
other science and engineering applications. Nanoparticle-assisted drug delivery, cell imaging and cancer therapy are
important biomedical applications of nanotechnology. Development of core-shell nanostructures that combine multiple
functions are of great interest for future nano-bio-technology
and biomedical applications. For example, core-shell nanostructures containing a chemotherapeutic drug and a fluorescent dye could be used to release the drug at sites of interest
while tracking the exact location of its delivery using imaging
methods employing the fluorescence of the dye molecules.
When organic dye molecules such as fluoroescein isothiocyanate (FITC) are exposed to harsh environments, they often
suffer from freely interacting with solvent molecules, which
can result in reduced performance of the dye. Encapsulation
of the organic fluorescent dye in a core-shell nanostructure
can not only add optical functionality, allowing the particles
to be tracked and imaged easily, but can also enhance the
stability and performance of the dye by protecting it from
photobleaching and quenching from the background
medium.
Several groups have employed fluorescent core-shell nanoparticles to add functional layers that can destroy disease
causing cells, including cancerous cells. Mesoporous fluorescent silica particles developed by adding molecular sieve
materials such as MCM-48 were used for site-oriented delivery of chemotherapeutic drugs and cell imaging. Recently,
gold coated silica nanoparticles have been used to kill tumor
cells via hyperthermia treatments. However, these treatment
methods employing either the conventional chemotherapeutic drugs or hyperthermia suffer from lack of significant cell
specificity. Both methods can kill normal cells along with
cancer cells of interest.
In a recent work (K. M. Reddy, K. Feris, 1. Bell, D. G.
Wingett, C. Hanley, A. Puunoose, Appl. Phys. Lett. 90,
213902 (2007)), our group demonstrated the ability of identical-13 nm ZnO nanoparticles to kill bacterial cells at concentrations that are not toxic to human T lymphocytes.
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Fluorescein isothiocyanate (FITC)-encapsulated Si0 2
core-shell particles with a nanoscale ZnO finishing layer have
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been synthesized for the first time as multifunctional "smart"
nanostructures. Detailed characterization studies confirmed
the formation of an outer ZnO layer on the Si0 2 -FITC core.
These -200 nm sized particles showed promise toward cell
imaging and cellular uptake studies using the bacterinm
Escherichia coli and 1urkat cancer cells, respectively. The
FITC encapsulated ZnO particles demonstrated excellent
selectivity in preferentially killing 1urkat cancer cells with
minimal toxicity to normal primary immune cells (18% and
75% viability remaining, respectively, after exposure to 60
flg/mL) and inhibited the growth of both gram -positive and
gram-negative bacteria at concentrations ~250-500 flg/mL
(for Staphylococcus aureus and Escherichia coli, respectively). These results indicate that the novel FITC encapsulated multifunctional particles with nanoscale ZnO surface
layer can be used as smart nanostructures for particle tracking, cell imaging, antibacterial treatments and cancer therapy.

phine oxide (TOPO), 1.0 g polyethylene glycol (PEG), and
0.5 mL ofFITC-APTMS were added to a flask containing 200
mL of diethylene glycol (DEG) solution and stirred for 10
min. Then, 0.5 mL oftetraethylorthosilicate (TEOS), 2.0 mL
of water, and 1.5 mL of ammoninm hydroxide (28-30%) were
added into the above mixture and stirred for 1.5 h to form
FITC-Si0 2 cores. A part of this sample was separated at this
point to obtain FITC encapsulated silica particles to compare
their properties with FITC encapsulated ZnO particles. The
resulting mixture was then heated to 100° C. and 2.6 g of Zinc
acetylacetonate, Zn(CH 3 COCHCOCH 3 )2 was introduced.
Following this, the mixture was heated to 160° C. and maintained at that temperature for 2 h. The heating was then
stopped to allow the mixture to cool down to room temperature with continuous stirring for 1 h. The resulting FITC-ZnO
particles were purified by centrifugation at 10,000 rpm for 8
min. The supernatant was removed and replaced with ethanol.
This process was repeated for several times until no yellow
fluorescence of FITC was observed in the supernatant. Subsequently, the resultant particles were dried in an oven.
Characterization of Fluorescent FITC-ZnO Particles:
The morphology, size, structure, and composition ofFITCZnO particles were thoroughly investigated using transmission electron microscopy (TEM), X-ray diffraction (XRD),
X-ray photoelectron spectroscopy (XPS), and UV-vis spectroscopy. (1. Hays, K. M. Reddy, N.Y. Graces, M. H. Engelhard, V. Shutthanadan, M. Luo, C. Xu, N.C. Giles, C. Wang,
S. Thevuthasan, A. Punnoose, 1. Phys: Condens. Matter. 19,
266203 (2007)). In addition to the as-prepared samples, XPS
spectra were also collected after removing 2, 5, 8, and 11 nm
thick layers successively viaAr+ ion sputtering using a 2 kV
Ar+ ion beam rastered over a 4 mm diameter sample area
during 2 RPM sample rotation.
The fluorescence properties and stability of FITC-ZnO
particles were studied using fluorescence spectroscopy and
flow cytometry. For flow cytometric analysis, a 3-color Epics
XL cytometer (Coulter, Miami, Fla.) was used to evaluate the
photobleaching and quenching effects ofFITC-ZnO particle
aggregates. FITC-ZnO particles were analyzed after keeping
in oxygen-rich water for varying times, and in some cases,
after subjecting the samples to illumination using a mercury
lamp (Model SP200 spectrum tube, with 5000V and 10 rnA
output) and then resuspended in oxygen-rich water prior to
analysis, and a minimnm of 10,000 particle aggregates monitored for changes in relative fluorescence using a 488 nm
argon laser.
Fluorescence spectra of FITC-ZnO particles were measured at room temperature using a Horiba 1obin Yvon T 64000
spectrometer equipped with Hamamatsu R943-02 GaAs photomultiplier. Two lines ofa He---Cd laser, 441.6 and 325 nm,
were used for excitation. The photobleaching and quenching
effects of the FITC-ZnO nanoparticles were investigated by
measuring the fluorescence data at fixed time intervals after
subjecting the samples to low power laser light (wavelength
441.6 nm, power density -80 W cm- 2 ). Similar data were also
taken from pure FITC sample under identical conditions for
comparison.
Utility tests for cell imaging: The feasibility of using FITCZnO particles for particle tracking/cell imaging in biological
environments was investigated using fluorescence confocal
image microscopy (FCIM). Stationary phase E. coli cells
were exposed to FITC-ZnO particles and PI for 15 minutes at
room temperature. FITC-ZnO and PI exposed cells were
spotted on a glass slide, allowed to air dry, and viewed using
a Zeiss LSM 5 Pascal confocal microscope. Additional slides
were prepared with E. coli cells exposed to either the FITCZnO particles or PI alone to determine ifthere was any over-
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BRIEF DESCRIPTION OF THE DRAWINGS
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FIG. 1 is a collection of two charts and two transmission
electron microscopy (TEM) images of FITC-ZnO particles.
FIG. 2 is a collection offour charts about X-ray photoelectron spectroscopy (XPS) investigation of core-shell FITCZnO particles.
FIG. 3 is a chart about UV-vis-NIR absorption spectra of
FITC-ZnO particles.
FIG. 4 is a collection of four charts about fluorescence
characterization of FITC-ZnO particles.
FIG. 5 is a collection of three charts about flow cytometry
examination ofFITC-ZnO particles.
FIG. 6 is three microscopic cell images with FITC-ZnO
particles.
FIG. 7 is four microscopic images about uptake of FITCZnO particles by 1urkat cancer cells.
FIG. 8 is a collection of two charts about concentration and
time-dependent cytotoxicity of FITC-ZnO particles for bacterial systems.
FIG. 9 is a chart about concentration-dependent cytotoxicity of FITC-ZnO particles for leukemia T cells and normal
human T cells.
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Referring to the figures, there are shown some, but not the
only, embodiments of the invented ZnO-encapsulated fluorescent dye particles, preferably FITC-ZnO particles. In the
description that follows are some, but not the only, invented
methods of making and using said ZnO-encapsulated fluorescent dye particles.

50

Experimental Section
Synthesis ofFITC-ZnO Particles:
FITC-ZnO particles were synthesized by forced hydrolysis
and condensation of FITC-binding silane and silicate to
obtain the FITC-Si0 2 core, followed by the formation of ZnO
surface layer using zinc salt. In a typical synthesis, 10 mg
(0.026 mmol) of FITC was dissolved in 3.0 mL ethanol by
stirring for 20 min, followed by the addition of 20 flL (0.085
mmol) of vacuum-distilled (3-aminopropyl)-trimethoxysilane (APTMS). The reaction continued for 24 h under stirring
in the dark. The amino group of the APTMS reacts with the
isothiocyanate group ofFITC to form N-l-(3-triethoxysilylpropyl)-N'-fluoresceyl thiourea, and the resulting solution is
referred to as FITC-APTMS. Second, 0.77 g tri-n-octylphos-

55

60

65
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lap in the fluorescence emission of the two dyes. The confocal
microscope was configured to prevent detection ofFITC fluorescence in the PI channel and vice versa. For cellular uptake
and internalization studies, log phase lurkat cells were
adhered to poly-d-lysine treated glass bottom chamber slides
(MatTek, Ashland, Mass.), treated with 0.25 mM FITC-ZnO
particles for 8 hours, washed three times in PBS/3% fetal
bovine serum (FBS) to remove extracellular NP, stained with
a PE-conjugated antibody specific to the CD3 cell surface
protein (Beckman Coulter, Miami, Fla.) as previously
described using 8 fll/200 fll of cells, and washed a final time in
PBS/3% FBS. For confocal analysis, control slides were prepared to verify the absence of spectral overlap between the
two dyes after appropriate instrument set-up.

Results and Discussion
Synthesis, Structure and Composition of the Multi-Layered
Core-Shell Architecture:
In this work, we have synthesized multifunctional fluorescent core-shell particles with a ZnO outer layer using a novel
one-pot methodology of successive hydrolysis and condensation ofFITC-incorporating silicate and zinc salt. This procedure is based on the methods used by several groups to
synthesize colloidal silica particles encapsulated with organic
fluorophores (A. Bums, H. Ow, U. Wiesner, Chern. Soc. Rev.
35, 1028 (2006); and H. Ow, D. R. Larson, M. Srivatsava, B.
A. Baird, W. W. Webb, U. Wiesner, Nano Lett. 5, 113 (2005)),
but modified to include the additional ZnO layer, as described
in our earlier work. The novelty that this work brings to the
field is the addition of the outer ZnO nanolayer to the FITC
encapsulated silica that display an additional functionality of
selective toxicity to certain types of bacteria and cancer cells.
In the following, we demonstrate that the particles have a
core-shell structure and they maintain the fluorescence properties of the encapsulated dye and the selective toxicity of the
outer ZnO nanolayer.
The FITC encapsulated fluorescent ZnO particles were
light orange in color. FIG. 1 (panels labeled A-D) shows
X-ray diffraction patterns and HRTEM images of core-shell
FITC-ZnO particles. FIG. lA illustrates X-ray diffraction
spectra of FITC-ZnO particles, along with those of pure
samples of PEG, FITC, ZnO and Si0 2 particles, wherein a
schematic illustration of the FITC-ZnO particles is shown in
the inset of FIG. lA. FIG. IB shows TEM images of FITCZnO particles, where the inset on the left shows a group of
FITC encapsulated ZnO particles and the right inset shows a
TEM image of the FITC encapsulated Si0 2 particles taken
out during the synthesis ofFITC-ZnO particles. FIG. lC is a
plot showing the size distribution ofFITC-ZnO particles, and
FIG. ID is a high-resolution TEM image of the outer shell of
the FITC-ZnO particles illustrating the ZnO crystallites forming the outer layer.
The inset ofFIG.IA shows the schematic representation of
the particle with the expected core-shell structure. X-ray diffraction (XRD) measurements were used to investigate the
material composition and chemical phases present in the
FITC-ZnO particles, comparing to those of pure samples of
Si0 2 and ZnO particles prepared under similar conditions.
The XRD spectrum of the FITC-ZnO particles shown in FIG.
lA clearly has all the expected ZnO peaks in addition to the
strongest peaks of polyethylene glycol (PEG) used for size
control and capping agent for Si0 2 , and for improving the
hydrophilicity ofFITC-ZnO particles. Only a broad peak was
observed for Si0 2 indicating poor crystallinity. Average size
of the ZnO crystallites were estimated using the Scherrer
equation, L=0.9A/~ cos 8 (where 8 is the XRD peak position,
A is the x-ray wavelength and ~ is the width of the measured
peak after correcting instrumental width). The estimated size
of -10 nm suggests that the outer ZnO layer was fonned by
attaching such nanocrystals on the surface ofFITC encapsulated Si0 2 structures. Transmission electron microscopy
(TEM) measurements were performed to investigate the particle size, shape and size distribution of the fluorescent FITCZnO particles.
FIG. IB shows spherical FITC-ZnO particles of average
size -200 nm and with a size distribution shown in FIG. Ie.
The TEM data also confirms the XRD result that the surface
ZnO layer is formed via accumulation of -1 0 nm sized ZnO
crystallites (FIG. ID). The presence of the relatively less
electron transparent ZnO nanoparticle layer on the outer surface prevented clear observation of the core-shell structure.
To obtain better insight on this, a part of the sample was
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Cancer/Anti-Bacteria Treatment Applications:
Toxicity of the FITC-ZnO particles toward human T lymphocytes and lurkat cancer cells was determined as follows.
First, peripheral blood mononuclear cells (PBMC) were
obtained by Ficoll-Hypaque (Histopaque-1077, Sigma, St.
Louis, Mo.) gradient centrifugation using heparinized blood
samples from healthy volunteers. This cell mixture was
washed 3 times with Hank's buffer (Sigma), and incubated at
1.0x10 6 cells/mL in RPMI-1640 (Sigma) containing 10%
fetal bovine serum. CD4+ T cells were subsequently isolated
using negative immunomagnetic selection per manufacturer's instructions using a cocktail of antibodies against
CD45RO, CD8, CD19, CD14, CD16, CD56, CD8, and glycophorin A (StemCell Technologies, Vancouver, B.e.) with
collection of unlabeled T cells (typically >96% CD4+ and
>93% viable as assessed by flow cytometry). Purified CD4 +T
cells, or the lurkat T cell line (ATCC, Rockville, Md.) were
cultured in RPMIIlO% FCS at 5x105 cells/mL in 96-well
microtiter plates and treated with various concentrations of
FITC-ZnO particles resuspended in PBS. For the delivery of
FITC-ZnO particles to cell cultures, a stock solution was
made and sonicated for 10 minutes. Then immediately prior
to dispensing into each individual cell culture well, particles
were vortexed and immediately dispensed. This process was
repeated for each culture well, to reduce differential particle
delivery due to sedimentation. After 24 h of culture, cells
were stained with propidium iodide (PI; BD Biosciences, San
lose, Calif.) to monitor loss of membrane integrity as previously reported and 10 flL of fluorescently labeled microspheres (Molecular Probes, Eugene, Oreg.) added to each
sample to allow for the absolute detennination of cell numbers. Flow cytometry was used to analyze a minimum of
10,000 T cells per sample to determine changes in PI staining
and quantification of cell death.
Similar toxicity studies ofFITC-ZnO particles on bacteria
were conducted. FITC-ZnO particles were resuspended in
sterile 0.9% NaCl aqueous solution, then sonicated for 15
minutes in a bath sonicator and continuously agitated by
pipetting prior to dispensing to LB media for toxicity testing.
For inhibitory threshold detennination resuspended FITCZnO particles were added to Luria-Bertani (LB) agar to different final concentrations (0-1250 DglmL), as described in
our earlier work. Time dependent toxicity tests were performed as follows. Equal densities of overnight E. coli cultures (based on OD600nm values) were used to inoculate LB
broth with and without FITC-ZnO particles. Broth cultures
were incubated with shaking as above, sampled repeatedly,
and viable cell densities measured via CFU enumeration by
plating on particle free LB media.
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separated during the synthesis process before adding the ZnO
precursor. This provided FITC encapsulated silica particles
before attaching the ZnO nanolayer on their surface. TEM of
these FITC-Si0 2 particles showed an electron transparent
core region (brighter region) presumably containing the FITC
and the spherical silica shell (darker region) as shown in FIG.
1B (top right inset).
X-ray photoelectron spectroscopy (XPS) measurements
were carried out to investigate the core-shell architecture of
the fluorescent ZnO particles through layer-by-layer sputtering. FIG. 2 (panels labeled A-D) shows XPS investigation of
core-shell FITC-ZnO particles, wherein FIG. 2A shows the
XPS survey spectra of as-prepared FITC-ZnO particles and
the same after removing 11 nm using Ar ion sputtering, a
"whole survey spectrum." FIGS. 2B, C and D show the highresolution XPS spectra of the Zn 2P3/2' Si 2p, and N 1s
regions, respectively, collected from as-prepared samples as
well as from samples after successively removing 2, 5, 8 and
11 nm thick layers. Thus, FIGS. 2B-D show the high resolution core level spectra of the Zn 2P3/2 (FIG. 2B), Si 2p (FIG.
2C) and N 1s (FIG. 2D) regions, which are representative and
distinct constituents of the ZnO, Si0 2 and FITC layers. FIG.
2B shows the Zn 2P3/2 peak at 1021.4 eV which is the
expected binding energy range for pure ZnO. The observed
increase in the peak intensity on going from the surface of the
as-prepared particles to 8 nm deep indicated more efficient
packing of ZnO crystallites with increasing depth. However,
further sputter removal up to 11 nm showed a drastic reduction in the peak intensity and -1.0 eV increase in the binding
energy. This is indicative of a significant change in the chemi cal environment, most likely a transition from the ZnO surface layer to a Si0 2 inner layer. Based on the observed presence of Zn in particles that underwent an 11 nm sputter
removal and considering the ~12 nm analysis depth, an
approximate thickness of 11-23 nm may be estimated for the
ZnO surface layer. This estimate matches with the conclusion
from the TEM and XRD data that the surface ZnO layer was
formed by attaching -10 nm sized ZnO crystallites on the
Si0 2 surface. These results are further confirmed by the Si 2p
peaks shown in FIG. 2C. Weaker Si 2p peaks are present even
in the as-prepared samples. The nominal analysis depth of
XPS is in the ~12 nm range and therefore, if the Si0 2 layer
starts about 8-12 nm below the particle surface, a weak Si 2p
signal from the outer walls of the Si0 2 layeris expected in the
as-prepared sample as well as in samples after removing few
nm thick layers. However, similar to the case of Zn 2P3/2 data
shown in FIG. 2B, the Si 2p peak also shows dramatic
changes when a 11 nm thick layer is removed from the sample
(FIG. 2C). The Si 2p signal intensity increases significantly
and shifts to higher energies by 1.4 eY. This large shift indicating a significant increase in the Si 2p binding energy can be
attributed to the covalent bonding ofSi ions on the inner walls
of the Si0 2 layer with FITC molecules.
Recalling that FITC is bound covalently to the silica matrix
via the (3-aminopropyl)-trimethoxysilane (APTMS) coupIing agent, the results shown in FIGS. 2B and 2C indicate a
layered structure of the order of ZnO-Si0 2-APTMS-FITC
as we proceed from the surface to the core of the FITC-ZnO
particle. At the boundaries of these different layers, some
level of mixed interface is also expected. The N Is peak
arising from the FITC molecules shown in FIG. 2d further
support the presence of such a layered architecture for the
FITC-ZnO particles. Unlike the Si 2p peak, no N Is peak
(397.8 eV) was observed in the as-prepared samples suggesting that a measurable concentration of FITC molecules are
not present in the surface region of the particles, at least in the
~ 12 nm analysis depth range ofXPS. The complete absence

of this peak in as-prepared samples as well as in the ones after
the sputter removal of up to 8 nm, and its subsequent strong
presence after removing 11 nm confirm that FITC is mostly
concentrated in the core of the particles. However, since the
amino group of the APTMS reacts with the isothiocyanate
group of FITC and this coupled FITC-APTMS participates
with tetraethylorthosilicate (TEOS) in the hydrolysis/condensation reactions, some distribution of FITC molecules in
the silica shell, especially in the inner layer is a likely possibility.
The binding energy shifts of the Zn 2P3/2 peak and the Si 2p
peak in the 11 nm sputter removed sample are not due to any
random changes or charging effects because (i) the sample
charging has been continuously compensated during the sputtering process by comparing the effect on known standards,
(ii) if the binding energy shifts are due to any charging effect,
it should display a gradual and systematic shift as sputtering
(or charging) progresses, (iii) the peak shifts at 11 nm sputtering is associated with large changes in the intensities also
indicating that the effect is related to transition between layers
and the associated changes in the concentration of the
elemental constituents, and (iv) the change in the XPS peaks
at 11 nm sputtering coincides with the appearance of the N 1s
signal from the FITC layer, again suggesting that the
observed binding energy changes are associated with changes
in the chemical environmentlbinding as data is collected progressively from different layers.
The optical properties ofFITC-ZnO particles in water were
studied using UV-vis-NIR spectrophotometry in the absorption mode. The spectrum of the FITC encapsulated ZnO
samples was the sum of the spectral features observed in pure
samples of -10 nm ZnO particles, -150 nm Si0 2 and pure
FITC measured separately, as illustrated in the absorption
spectra in FIG. 3. FIG. 3 discloses UV-vis-NIR absorption
spectra ofFITC-ZnO particles. The optical spectra ofFITCZnO particles dispersed in water (40 mg/mL) along with pure
samples of FITC (1.2xlO- 6 M), ZnO and Si0 2, and of the
FITC-ZnO particles after treatment of 1.5% NaOH to release
the encapsulated FITC by dissolving the ZnO-Si0 2 shells
(NaOH treated FITC-ZnO).
The features near 362 nm in pure ZnO and FITC-ZnO are
the well expected absorption edges corresponding to the band
gap of ZnO. The absorption peak at 489 nm of the encapsulated FITC molecules was lower than 494 nm observed for
pure FITC. This small blue shift could be the result of covalent binding of the FITC molecules on the silica shell as also
evident from the XPS data discussed earlier, and/or the presence of electron rich ZnO surface layer that might electromagnetically interact with the fluorophore. The charges in
ZnO and/or near the polar ZnO-Si0 2 interface might give
rise to long-range electrostatic potential, which might extend
through the silica layer to the FITC core. Another possible
reason might be a direct binding of a fraction of the FITC
molecules distributed in the silica shell (through the pores
present in the silica layer) with ZnO nanocrystals. Additionally, UV-vis-NIR measurements were conducted for the
FITC-ZnO particles after treating with 1.5% NaOH to release
the encapsulated dye. The NaOH addition dissolves the ZnO
layer as evident from the disappearance of the band edge
(FIG. 3). From this experiment, itwas found that 40 mg/mL of
the FITC-ZnO particles dispersed in water might have encapsulated FITC equivalent to 1.2x 10- 6 M ofFITC, estimated by
comparing the UV absorbance with that of pure dye solution.
Fluorescent Emission Characteristics:
The FITC-ZnO particles are capable of emitting strong
fluorescence both in the visible and UV wavelength ranges
originating from FITC and ZnO layers, respectively. FIG. 4
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(panels labeled A-D) shows fluorescence characterization of
FITC-ZnO particles, wherein FIG. 4A shows fluorescence
emission spectra ofFITC-ZnO particles and FIG. 4B shows
fluorescence emission spectra of pure FITC (1.2xlO- 6 M),
both of which were dispersed in oxygen-rich water and measured as a function of time shown. FIG. 4C shows the comparison ofUV fluorescence spectra between FITC-ZnO particles and pure ZnO nanoparticles. The inset in FIG. 4C shows
the FITC fluorescence from pure FITC, FITC encapsulated
Si0 2 and FITC encapsulated ZnO; and the plot in FIG. 4D
shows the relative decrease of fluorescence intensity as a
function of exposure time for pure FITC sample and FITC
encapsulated ZnO particles.
Specifically, FIGS. 4A and 4B show the visible region
fluorescence emission of FITC-ZnO particles and pure FITC
(dispersed in water), respectively, excited by the 441.6 nm
laser light. The encapsulation of FITC in the Si0 2 and ZnO
layered shell might have caused a slight red shift and broadening, as shown in the insert of FIG. 4C. Interestingly, dye
encapsulated Si0 2 displayed a blue shift due to the covalent
binding of the dye molecules as observed by other groups
also. The change of the FITC fluorescence emission when the
additional ZnO layer was added is attributed to the electromagnetic interactions between the ZnO layer and the FITC
molecules and/or a direct binding of some FITC molecules
distributed in the silica shell as discussed earlier. Colloidal
metal layers on silica nanoparticles have been reported to
exhibit plasmon resonance and can significantly modifY the
fluorescence emission properties of the encapsulated dye
molecules. The polar semiconducting ZnO surface layer
might also have caused an electromagnetic interaction with
FITC to exhibit the observed changes. Similar experiments
employing a 325 nm UV laser produced strong UV fluorescence from ZnO layer shown in FIG. 4C. The peak emission
from ZnO in FITC-ZnO particles is similar to that of -10
nm-sized pure ZnO particles, but occurs at slightly longer
wavelength (392 nm) compared to the emission from pure
ZnO (387 n). This shift is most likely due to the presence of
the Si0 2 layer and/or the binding ofFITC molecules present
in the silica layer in close proximity. The UV laser and the
resulting UV fluorescence from the ZnO layer also excite
green fluorescence from the FITC dye, as can be seen in inset
of FIG. 4C. Several groups have recently began developing
ratiometric pH sensors which rely on the changes in the
intensity, wavelength as well as other fluorescence characteristics of a dye attached to the surface of a core-shell nanoparticle due to analyte interactions. The inner dye encapsulated
in the silica particles acts as an internal standard for the
ratiometric analysis. Our demonstrated ability to integrate an
additional layer of UV fluorescent ZnO thus provides the
core-shell particles two fluorescence sources. By choosing
appropriate dye molecules and layered architectures, ZnO
based core-shell particles could also form efficient platforms
for ratiometric sensing applications.
The utility of fluorescent particles for tracking and imaging
applications depends also on the environmental and photostability of the fluorescence emission. The fluorescence emission of a fluorophore is often affected by the molecular interaction between the dye and various active species in the
solvent such as dissolved oxygen. To investigate the environmental and photo-stability, the FITC-ZnO particles were dispersed in oxygen-rich water and its fluorescence emission
was recorded using a fluorescence spectrometer as a function
of the time oflaser exposure, shown in FIG. 4A. The observed
changes are compared to a similar measurement conducted
on micromolar concentrations of pure FITC dissolved in
water, shown in FIG. 4B. A plot of integrated fluorescence

intensity versus the laser light exposure time (441.6 nm line),
shown in FIG. 4D, suggests that the Si0 2 -ZnO layer offers
protection against photobleaching of the FITC molecules.
The decay time constants to for pure FITC and the FITC-ZnO
particles estimated from fitting the data shown in FIG. 4dwith
exponential decay function e- tito were 17 and 27 minutes
respectively. Evidently, the photo-stability ofFITC-Si0 2 particles reported by other groups is much more significant than
our results. We believe that the reasons for this relatively
weaker photo-stability might be the high concentration of
FITC in the core of the particles and the less uniform distribution of FITC in Si0 2 . Future efforts will focus on improving the photo-stability.
Flow cytometry is a commonly used biological/biomedical
research tool and the ability of the fluorescent FITC-ZnO
particles for use with this technique was carefully investigated (FIG. 5). FIG. 5 (panels labeled A-D) shows flow
cytometry examination of FITC-ZnO particles. The data for
FITC-ZnO particles taken (FIG. SA) immediately after dispersing in oxygen-free water, (FIG. 5B) after keeping in
oxygen-rich water for 2 months and (FIG. 5C) after exposure
to a mercury lamp for 2 h. Nanoparticle aggregates were gated
based on their forward scatter and side scattering light properties on a log scale with collection of 10,000 events. This
identical gating region was subsequently used to determine
the relative mean FLI fluorescence signal ofFITC-ZnO particles after various treatments. Unlabeled ZnO particles were
used as the control sample in these experiments and numbers
inside parenthesis indicate mean fluorescence intensity (MFI)
ofFITC-ZnO particles.
A high percentage (98%) of the freshly synthesized FITCZnO particle aggregates dispersed in oxygen-free water was
derivatively fluorescent. As shown in FIG. Sa, a strong fluorescent signal (mean fluorescence intensity, MFI=208.2) was
observed in freshly prepared FITC encapsulated particle
aggregates compared to the unlabeled pure ZnO particles.
Long tern protection against photobleaching was also investigated using flow cytometry (FIG. 5, panels labeled A-C).
For these experiments, FITC-ZnO particles were either kept
in oxygen-rich water for a significantly longer period of two
months (FIG. 5B) or illuminated for 2 h with a mercury lamp
and then dispersed in oxygen-rich water media (FIG. 5C).
Based on comparisons of the fluorescence intensities to
freshly prepared FITC-ZnO particle aggregates (FIG. SA,
MFI 208.2), the fluorescence signal remained considerably
stable (between 59-72%) either after storage for two months
(FIG. 5B, MFI 149.5) or exposure to strong light (FIG. 5C,
MFI 123) suggesting the vital role of the Si0 2 -ZnO shell in
protecting the dye from bleaching.
Biomedical Applications, Cell Imaging, Particle Uptake and
Selective Toxicity:
We demonstrate the ability of FITC-ZnO particles for
potential use in four novel biomedical applications-(i) cell
imaging, (ii) eukaryotic cellular uptake of particles, (iii) antibacterial treatment and (iv) cancer treatment. Dye encapsulated silica particles have been used in the past for biological
imaging by attaching cell specific antibodies on the outer
silica surface. For example, Ow et a!. have successfully
labeled rat basophilic leukemia mast cells using antibody
(immunoglobulin E) adsorbed fluorescent silica particles and
the FceRI receptor available on these cells. It is often desirable to observe markers for extended periods of time against
the background of intrinsic cellular emissions. Accordingly,
we have investigated the ability ofFITC-ZnO particles (at 7.5
flglmL) dispersed in saline medium to image E. coli using the
green fluorescence of the particles (FIG. 6). E. coli cells were
simultaneously stained with FITC-doped ZnO particles
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(green fluorescence), and the vital dye (propidium iodide
(PI), red fluorescence). PI uptake by bacterial cells is dependent on loss of cell membrane integrity and is, therefore,
frequently used to indicate the extent of death in a cell population. Bacteria co-treated withFITC-ZnO and PI were examined by confocal microscopy to establish the ability of the
FITC-ZnO particles to stain/visualize bacterial cells (FIG. 6).
FIG. 6 (panels labeledA-C) shows cell imaging with FITCZnO particles. Confocal fluorescence microscopic images of
E. coli cells simultaneously treated with FITC-doped ZnO
particles (green fluorescence) and propidium iodide (PI, red
fluorescence), showing (FIG. 6A) fluorescence signal from
FITC-ZnO, (FIG. 6B) fluorescence signal from PI, and (FIG.
6C) overlay ofFITC-doped ZnO and PI signals, yellow cells
indicate dual stained cells.
Such a bivariate analysis allows for the discrimination of
intact cells (FITC only) and dead/non-viable cells (FITC and
PI). Visualization of the FITC-ZnO signal alone indicates that
the FITC-ZnO particles were associated with the bacterial
cells and emitting very bright green fluorescence (FIG. 6A).
Visualization of PI signal alone indicated presence of E. coli
cells with damaged and permeable cell membranes (FIG.
6B). By overlaying the FITC-ZnO and PI signals, a third
image was generated where E. coli cells stained with both
FITC-ZnO and PI appear yellow (FIG. 6C). The confocal
images clearly demonstrate that FITC-ZnO particles have an
excellent ability to image cells using common imaging techniques if they can be attached to cells of interest. This image
indicates that many of the FITC-ZnO associatedE. coli cells
are still viable (i.e. not many yellow cells in panel C) even
though the FITC-ZnO particles can be toxic to E. coli cells.
This is likely due to the short incubation time (15 minutes)
used to prepare the cells for imaging. The granular appearance of the E. coli cells (FIG. 6A) is due to the particulate
nature of the FITC-ZnO. As discussed above the FITC-ZnO
particles are -200 nm in diameter and close to the resolution
of the confocal microscope. The granular appearance of theE.
coli cells is likely due to adherence of the particles to the
external surface of the cells and the ability of the microscope
to resolve individual fluorescent particles or groups of particles. It may be noted that the purpose of this experiment is
only to demonstrate the potential ofFITC-ZnO particles as a
fluorescence probe and not to demonstrate selectivity in the
cell-nanoparticle (FITC-ZnO) interaction. For many cell
types, binding of cell specific antibodies might be necessary
for selective cell imaging applications.
Given that the size of the FITC-doped particles (-200 nm)
described in this study and the diameter of the imaged bacterial cells (-500 nm) are near the resolution capabilities of the
microscope, nanoparticle uptake and internalization studies
were performed on eukaryotic lurkat T cells as an example
system. The cells were treated with FITC-ZnO particles
(green fluorescence) for 8 h, and then washed extensively to
remove unattached extracellular particles and reduce background staining. Cells were then stained with a PE-conjugated antibody directed against the CD3 membrane-bound
protein (red fluorescence) and confocal images taken using
live cells to avoid internalization artifacts resulting from cell
fixation. FIG. 7 (panels labeled A-D) shows uptake ofFITCZnO particles by lurkat cancer cells. Confocal fluorescence
microscopic images of lurkat cancer cells treated with 0.25
mM FITC-ZnO particle (green fluorescence) for 8 hours and
stained with a PE-conjugated antibody specific to CD3 cell
surface protein (red fluorescence) with extensive washing to
remove extracellular NP. FIG. 7A depicts FITC-ZnO particles alone (after identical washing steps as samples containing cells) with an arrow indicating a typical particle of -200

nm. FIGS. 7B-D show consecutive cell images/slices of a
single cell. In FIG. 7C, an internalized particle of expected
200 nm size is indicated by an arrow and orthogonal viewing
was used to confirm particle intracellular localization.
FIG. 7 shows consecutive three-dimensional slices through
a single lurkat T cell (panels B-D) demonstrating the internalization of a green fluorescent FITC-ZnO particle with
intracellular localization being confirmed by viewing along
orthogonal directions (not shown). Individual confocal image
slices were taken at intervals of 200 nm thickness (comparable in size to the NP), thus only one internalized particle is
shown in the presented focal plane. However, at least six
internalized NP were observed in this particular cell with
additional internalizations likely but too proximate to the
plasma membrane to accurately resolve. The presence of such
internalized FITC-ZnO particles was confirmed in multiple
cells present on the culture slide. The image in panel A reflects
NP background staining and was obtained by treating a chamberslide with an identical concentration of NP and sample
washing regime as for cell cultures. It is important to note that
the goal of this particular study was to specifically show NP
uptake and intracellular localization in intact T cells following a short NP exposure prior to extensive cytotoxicity being
manifested in contrast to simply observing NP association
with cells (either extracellular or intracellular) as performed
for FIG. 6. Although no attempt has been made in this work to
ascertain the specific intracellular locations of the internalized particles, this important topic will be the subject matter
offuture studies.
We have recently shown that ZnO nanoparticles can selectively kill certain bacteria including E. coli and S. aureus.
Here we demonstrate a similar ability ofFITC-ZnO particles
to inhibit the growth of these two organisms. FIG. SA shows
the number of bacterial colony forming units (CFU) produced
by E. coli and S. aureus, after being grown in the presence of
FITC-ZnO particles overnight. FITC-ZnO particles prevented growth of E. coli at concentrations ~500 flglmL,
whereas concentrations ~250 flg/mL prevented growth of S.
aureus. The relative difference in toxicity ofFITC-ZnO particles to E. coli and S. aureus is similar to that previously
reported by our group for ZnO nanoparticles, 11 thus suggesting that the FITC-ZnO particles retain bacterial toxicity simi1ar to the pure ZnO nanoparticles. Additional, time dependent
exposures were conducted by enumerating CFU of E. coli
after 0, 6,12,24 and 48 hours ofFITC-ZnO particle exposure
(FIG. SB). Exposure to FITC-ZnO particles resulted in cell
death at concentrations of 800 flg/mL with number of viable
bacterial cells reduced to below 99.9% of the initial CFU/mL
within 12 hours. Viable cells were completely absent after 48
hours of treatment.
We have also recently determined that ZnO nanoparticles
show no significant toxicity to primary human T cells. To
determine whether FITC encapsulated particles with nanoscale ZnO outer surface can retain the ability of differentially
killing cancer cells, new experiments were conducted. Flow
cytometry was used to determine the number of viable human
cancerous T cells compared to normal primary T cells after
exposure to FITC-ZnO particles for 24 h. FIG. S shows concentration and time dependent cytotoxicity ofFITC-ZnO particles for bacterial systems. In FIG. SA, E. coli and S. aureus
cells were plated on LB media containing varying concentrations ofFITC-ZnO particles and incubated at 37° C. for 24 h.
Bars represent means±standard errors (n=3), ND indicates
concentrations at which no bacterial colonies were detected
after 48 h of incubation. In FIG. SB, there is shown effect of
ZnO NP exposure time on the viability and growth of E. coli.
(Plot presents mean CFU/mL (±standard error, n=3) of E.
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Coli exposed to 800 flg/L FITC-ZnO particles for 0,6,12,24,
and 48 hours, and * in the figure indicates measured ZnO
concentrations at which no CFU counts of E. coli were
observed.)
FIG. 9 shows that FITC-ZnO particles reduced cell viability of lurkat T leukemia cells to 8% at concentrations ~80
flg/mL, whereas the viability of normal CD4+ T cells at this
concentration remained at -61 %. Importantly, the differential
toxicity ofFITC-ZnO particles to cancerous and normal body
cells is similar to observations in our lab involving unlabeled
ZnO nanoparticles and indicates a potential new utility of
ZnO nanoparticles in the treatment of human cancers.
The novel biomedical applications---cell imaging, antibacterial treatment and cancer treatment---ofthe FITC-ZnO particles were conducted primarily to demonstrate their multifunctional nature. The performance of these particles in the
above demonstrated applications could be further enhanced
by improving the quality and properties of these particles
such as the particle size, uniformity, concentration of FITC
molecules per particles among others and these aspects will
be addressed in future studies.

3. Ability to preferentially kill cancer cells without comparable effects on normal human immune cells, suggesting its potential for nanomedicinal applications.
In addition the nanoscale ZnO layer might also offer new
opportunities in the fluorescence detection of biomolecules
by acting as a high surface area sensor platform. The UV
fluorescence of the incorporated ZnO layer and the internal
FITC fluorescence might provide new opportunities to detect
and quantifY surface attached biological and chemical species. Thus the multifunctional ZnO based fluorescent particles offers wide ranging opportunities in the nano-bio-technology applications.
Although this invention has been described above with
reference to particular means, materials, and embodiments, it
is to be understood that the invention is not limited to these
disclosed particulars, but extends instead to all equivalents
within the scope of the following claims.
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CONCLUSIONS
We have successfully developed fluorescent particles with
a nanoscale ZnO finishing layer using a novel one-pot synthesis methodology. Although dye encapsulated fluorescent
core-shell Si0 2 particles have been successfully synthesized
in the past with or without a metal layer on the outer surface,
this is the first time a semiconducting oxide layer, nanoscale
ZnO, has been attached to the particles. A variety of characterization studies, most notably systematic XPS measurements after sputter removing nanometer thick layers, confirmed the presence of the multi-layered architecture in the
order ZnO-Si0 2 -FITC as we proceed from the surface to the
core of the -200 nm sized particles. Such direct experimental
confirmation of the multi-layered structure in core-shell particles has not been demonstrated in the past. Optical studies
confirmed the ability of the ZnO based core-shell particles to
improve the environmental and photostability of the fluorescent dye. This makes these particles very useful for imaging
cells using their relatively stable fluorescent emission.
The additional ZnO layer in our core-shell particles opens up
a variety of applications using the attractive physical and
chemical properties of nanoscale ZnO including the following novel features demonstrated in this work:
1. Fluorescence probe for biological applications such as
cell imaging and particle tracking.
2. Selective toxicity to bacteria suggesting their potential
for antibacterial applications.
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The invention claimed is:
1. A composition of matter comprising a fluorescent dye
core nanostructure with a nanoscale ZnO surface layer.
2. The composition of claim 1 wherein the combination of
the core nanostructure and nanoscale surface layer are about
200nm.
3. The composition of claim 1 wherein the ZnO surface
layer is about 10 nm.
4. A method of making a fluorescent dye core nanostructure with a nanoscale ZnO surface layer, the method comprising successive hydrolysis and condensation of organic dye
molecules incorporating silicate and a zinc salt.
5. The method of claim 4 wherein the organic dye molecules comprise fluorescein isothiocyanate.
6. A method of making a fluorescent dye core nanostructure with a nanoscale Zn surface layer comprising:
first forming organic dye molecules encapsulated by Si0 2
by micro-emulsion; and
then coating the Si0 2 -encapsulated organic dye molecules
with a ZnO layer by hydrolysis of a zinc salt.
7. The method of claim 6 wherein the organic dye molecules comprise fluorescein isothiocyanate.
8. A method of killing cancer cells using a fluorescent dye
core nanostructure with a nanoscale ZnO surface layer while
monitoring the nanostructure with a fluorescence detector.
9. A method of killing bacteria cells using a fluorescent dye
core nanostructure with a nanoscale ZnO surface layer while
monitoring the nanostructure with a fluorescence detector.

* * * * *

